House Members Push for PBM Changes, Question Trump Drug Plan

House members push for PBM changes, question Trump drug plan

Lawmakers from both sides of the aisle came down hard on various sectors of the U.S. prescription drug supply during a hearing on Wednesday.

LIVE NOW: House Subcommittee Hearing Examining Drug Supply Chain to Lower Health Care Costs for All

The House Energy and Commerce Subcommittee on Health holds a hearing on “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain” at 10:15 a.m. ET on Feb. 11. ...

House subcommittee hearing discusses impacts of drug pricing on health care costs

The House Energy and Commerce Subcommittee on Health Feb. 11 hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain.” The AHA provided a statement for the hearing that shared concerns on issues such as efforts to weaken the 340B Drug Pricing Program, drug shortages and other drug supply chain disruptions, and private-payer policies undermining access and patient safety. The AHA…

HDA testifies at house hearing on health care affordability

WASHINGTON — Today, HDA president and CEO Chester “Chip” Davis testified before the House Energy and Commerce Health Subcommittee at a hearing on “Lowering Healthcare Costs: Examining the Healthcare Supply Chain.” In his testimony, Davis reaffirmed the critical role of distributors in the pharmaceutical supply chain and called on the subcommittee to explore the challenging reimbursement dynamics now facing providers. “While we can agree that the…

PCMA’s Opening Testimony at E&C Hearing on Prescription Drug Affordability

PBM Reform is Now Law; Time to Look at Real Causes of High Drug Prices (Washington, D.C.) — Today, David Marin, President and CEO of PCMA, joined a hearing at the Energy and Commerce Health Subcommittee focused on prescription drug affordability. The hearing, following the recent enactment of significant pharmacy benefit manager (PBM) legislation, includes representatives from the full prescription drug supply chain. Below is Marin’s opening tes…

E&C Health Subcommittee to hold Wednesday Hearing on Prescription Drug Supply Chain - 340B Report

A key U.S. House Subcommittee, which has jurisdiction over the 340B program, will hear testimony this week on the prescription [...] The post E&C Health Subcommittee to hold Wednesday Hearing on Prescription Drug Supply Chain appeared first on 340B Report.